Soothing Sore Relief — Class II drug recall D-1861-2019
Terminated recall by Ridge Properties, LLC, reported 2019-09-25, distributed nationwide. Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
| Recall number | D-1861-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ridge Properties, LLC, Salem, OR, United States |
| Recall initiated | 2019-08-09 |
| Classified | 2019-09-13 |
| Reported by FDA | 2019-09-25 |
| Terminated | 2023-07-12 |
| Distributed | Nationwide (US) |
| Quantity | 104.1 ounces |
| Reason classes | potency |
| NDC | 69804-0077-14, 69804-0077-15, 69804-0077-16 |
| Lot numbers | 1135 |
| Expiration dates | 2022-12-27 |
Product
Soothing Sore Relief (lidocaine) Liquid Gel, 4%, packaged in a) 1 Oz (NDC 69804-077-14), b) 2 Oz (NDC 69804-077-15), and c) 4 Oz (NDC 69804-077-16) bottles, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.
Reason for recall
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1861-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.